Liver resection for breast cancer metastasis: Does it improve survival?

Surgery Today

Volumn 38, Issue 4, 2008, Pages 293-299

  Lubrano, Jean ^a   Roman, Horace ^a   Tarrab, Sophie ^a   Resch, Benoit ^a   Marpeau, Loïc ^a   Scotté, Michel ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Adjuvant therapy; Breast cancer; Liver resection; Metastasis survival

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; NAVELBINE; TAMOXIFEN;

ADULT; ARTICLE; BLOOD TRANSFUSION; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LIVER RESECTION; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RADIODIAGNOSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43349094868     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3617-2     Document Type: Article

References (28)

1. Brun B, Benchalal M, Lebas C, Piedbois P, Lin M, Lebourgeois JP. Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment: prognostic factors. Cancer 1997;79(11):2137-2146.
2. Elias D, Lasser P, Spielmann M, May-Levin F, el Malt O, Thomas H, et al. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet 1991;172(6):461-464.
3. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP. The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994;55(1):26-31; discussion 32.
4. Maksan SM, Lehnert T, Bastert G, Herfarth C. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 2000;26(3):209-212.
5. Pocard M, Pouillart P, Asselain B, Salmon R. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 2000;26(2):155-159.
6. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003;185(2):158-164.
7. Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, et al. Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 2005;29(4):524-527.
8. Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000;127(4):383-389.
9. World Health Organization. World Health Organization handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.
10. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997;84(7):977-980.
11. Nakamura S, Suzuki S, Baba S. Resection of liver metastases of colorectal carcinoma. World J Surg 1997;21(7):741-747.
12. Harmon KE, Ryan JA Jr, Biehl TR, Lee FT. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 1999;177(5):402-404.
13. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 1987;5(1):55-61.
14. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 1999;56(1):67-78.
15. Koenders PG, Beex LV, Kloppenborg PW, Smals AG, Benraad TJ. Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 1992;21(3):173-180.
16. Pouillart P, Jouvet M, Palangie T, Garcia-Giralt E, Bretaudeau B, Dorval T, et al. Hepatic metastases of breast cancer. Analysis of the parameters which influence the response to chemotherapy. Ann Gastroenterol Hepatol (Paris) 1985;21(2):87-90.
17. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003;89(2):284-290.
18. O'Reilly SM, Richards MA, Rubens RD. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 1990;26(5):574-577.
19. Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL, Buzdar AU, et al. Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference. Cancer 1999;85(1):104-111.
20. Lee YT. Breast carcinoma: pattern of recurrence and metastasis after mastectomy. Am J Clin Oncol 1984;7(5):443-449.
21. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 2005;235(3):872-878.
22. Lind P, Igerc I, Beyer T, Reinprecht P, Hausegger K. Advantages and limitations of FDG PET in the follow-up of breast cancer. Eur J Nucl Med Mol Imaging 2004;31suppl 1:S125-S134.
23. Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351-358.
24. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000;59(2):177-184.
25. Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004;11(9):869-874.
26. Lee CG, McCormick B, Mazumdar M, Vetto J, Borgen PI. Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors. Int J Radiat Oncol Biol Phys 1992;23(5):969-975.
27. De Brux J. Histopathologie du sein. Paris: Masson; 1979.
28. Porter GJ, Evans AJ, Pinder SE, James JJ, Cornford EC, Burrell HC, et al. Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 2004;59(12):1094-1098.